Cephalexin Dry Syrup

Beta Lactams · Dry Syrup / Oral Suspension · 125mg/5ml, 250mg/5ml

Trade Information

Minimum Order Qty	100,000 bottles
Capacity	5 Million Bottles per month
Strength	125mg/5ml, 250mg/5ml
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Dry syrup bottle (glass / PET)
Bottle with measuring cup
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Cephalexin (as Cephalexin Monohydrate)
Dosage Form	Dry Syrup / Oral Suspension
Pack Size	Bottle with measuring device (60ml / 100ml) / Custom packing available
Storage	Store below 25°C in a dry place, protected from light and moisture
Shelf Life	24 months from date of manufacture

Description

Cephalexin is a first-generation cephalosporin antibiotic and a long-established workhorse for skin, soft tissue, and respiratory infections. It is listed on the WHO Model List of Essential Medicines and remains one of the most widely prescribed oral cephalosporins in primary care.

BioGalen manufactures Cephalexin as a paediatric dry syrup (125 mg/5 ml and 250 mg/5 ml on reconstitution). Its established safety, oral dosing, and affordability make it a high-volume primary-care antibiotic across the markets we serve.

Mechanism of Action

Cephalexin is a first-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, disrupting the cross-linking of peptidoglycan and causing cell lysis. As a first-generation agent it has strong activity against Gram-positive organisms such as staphylococci and streptococci, with more limited Gram-negative coverage. Its reliable oral absorption and well-established safety profile make it a dependable choice for common community-acquired infections.

Indications

Skin and soft tissue infections
Streptococcal pharyngitis and tonsillitis
Uncomplicated respiratory tract infections
Uncomplicated urinary tract infections
Bone and joint infections (as directed)

Available Variants

Cephalexin Dry Syrup 125mg/5ml
Cephalexin Dry Syrup 250mg/5ml

Frequently Asked Questions

What is Cephalexin mainly used for?

Cephalexin is a first-generation cephalosporin with strong Gram-positive activity, widely used for skin and soft tissue infections, streptococcal infections, and uncomplicated respiratory and urinary infections, making it a primary-care formulary staple.

How does Cephalexin differ from Cefixime?

Cephalexin is a first-generation cephalosporin focused on Gram-positive infections such as skin and soft tissue infections, while Cefixime is a third-generation cephalosporin with broader Gram-negative activity used for infections such as typhoid and UTIs. They serve different clinical roles.

What forms of Cephalexin does BioGalen manufacture?

BioGalen manufactures Cephalexin as a paediatric dry syrup (125 mg/5 ml and 250 mg/5 ml on reconstitution), under WHO-GMP with CTD and ACTD dossiers available.

Explore More

Interested in Cephalexin Dry Syrup?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form